Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only Get Premium

PRTA Prothena Corp Public Ltd Co

Price (delayed)

$4.59

Market cap

$247.07M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.05

Enterprise value

-$160.67M

Prothena Corporation plc is a late-stage clinical company with expertise in protein dysregulation and a diverse pipeline of novel investigational therapeutics with the potential to change the course of devastating ...

Highlights
The company's gross profit has surged by 55% YoY and by 2.1% QoQ
Prothena's revenue has soared by 55% YoY and by 2.1% from the previous quarter
The quick ratio has declined by 32% year-on-year and by 11% since the previous quarter
The company's equity fell by 13% YoY and by 10% QoQ

Key stats

What are the main financial stats of PRTA
Market
Shares outstanding
53.83M
Market cap
$247.07M
Enterprise value
-$160.67M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.56
Price to sales (P/S)
1.79
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
-1.16
Earnings
Revenue
$137.94M
Gross profit
$137.94M
Operating income
-$138.61M
Net income
-$110.27M
EBIT
-$115.86M
EBITDA
-$112.26M
Free cash flow
-$130.6M
Per share
EPS
-$2.05
EPS diluted
-$2.07
Free cash flow per share
-$2.43
Book value per share
$8.13
Revenue per share
$2.56
TBVPS
$9.2
Balance sheet
Total assets
$495.34M
Total liabilities
$57.66M
Debt
$10.2M
Equity
$437.68M
Working capital
$387.71M
Liquidity
Debt to equity
0.02
Current ratio
9
Quick ratio
8.62
Net debt/EBITDA
3.63
Margins
EBITDA margin
-81.4%
Gross margin
100%
Net margin
-79.9%
Operating margin
-100.5%
Efficiency
Return on assets
-19.3%
Return on equity
-21.6%
Return on invested capital
-280.7%
Return on capital employed
-25.9%
Return on sales
-84%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

PRTA stock price

How has the Prothena stock price performed over time
Intraday
-2.34%
1 week
-30.24%
1 month
-50.11%
1 year
-77.29%
YTD
-66.86%
QTD
-62.91%

Financial performance

How have Prothena's revenue and profit performed over time
Revenue
$137.94M
Gross profit
$137.94M
Operating income
-$138.61M
Net income
-$110.27M
Gross margin
100%
Net margin
-79.9%

PRTA financials

The operating margin has soared by 59% year-on-year and by 12% since the previous quarter
Prothena's net margin has soared by 59% YoY and by 12% from the previous quarter
The company's gross profit has surged by 55% YoY and by 2.1% QoQ
Prothena's revenue has soared by 55% YoY and by 2.1% from the previous quarter

Price vs fundamentals

How does PRTA's price correlate with its fundamentals

PRTA Price vs fundamentals

PRTA Earnings waterfall

PRTA Price vs fair value

Growth

What is Prothena's growth rate over time

PRTA growth chart

Valuation

What is Prothena stock price valuation
P/E
N/A
P/B
0.56
P/S
1.79
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
-1.16

Valuation vs average

Price to earnings (P/E)

The company's EPS rose by 36% YoY and by 10% QoQ

Price to book (P/B)

PRTA's price to book (P/B) is 85% lower than its 5-year quarterly average of 3.8 and 67% lower than its last 4 quarters average of 1.7
The company's equity fell by 13% YoY and by 10% QoQ

Price to sales (P/S)

PRTA's price to sales (P/S) is 99% lower than its 5-year quarterly average of 182.6 and 68% lower than its last 4 quarters average of 5.6
Prothena's revenue has soared by 55% YoY and by 2.1% from the previous quarter

Efficiency

How efficient is Prothena business performance
The ROIC has soared by 62% YoY and by 7% from the previous quarter
The company's return on sales has surged by 59% YoY and by 12% QoQ
The ROE has increased by 29% YoY and by 7% from the previous quarter
Prothena's return on assets has increased by 22% YoY and by 4.9% QoQ

Dividends

What is PRTA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for PRTA.

Financial health

How did Prothena financials performed over time

Assets vs liabilities

The total liabilities has dropped by 52% year-on-year and by 4.2% since the previous quarter
The quick ratio has declined by 32% year-on-year and by 11% since the previous quarter

Debt vs equity

Prothena's debt is 98% less than its equity
Prothena's debt has decreased by 18% YoY and by 6% from the previous quarter
The company's equity fell by 13% YoY and by 10% QoQ

Balance sheet

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.